These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2894233)

  • 21. Treatment of multiple myeloma with deoxycoformycin.
    Belch AR; Henderson JF; Brox LW
    Cancer Chemother Pharmacol; 1985; 14(1):49-52. PubMed ID: 3871175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo effect of deoxycoformycin in human T cell leukemia.
    Yu AL; Kung FH; Bakay B; Nyhan WL
    Adv Exp Med Biol; 1979; 122B():373-9. PubMed ID: 397762
    [No Abstract]   [Full Text] [Related]  

  • 23. Exploiting biochemical differences in leukemia.
    Coleman MS; Grever MR
    Adv Exp Med Biol; 1984; 165 Pt B():315-20. PubMed ID: 6609538
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful remission induction with deoxycoformycin in elderly patients with T-helper prolymphocytic leukaemia.
    el'Agnaf MR; Ennis KE; Morris TC; Robertson JH; Markey G; Alexander HD
    Br J Haematol; 1986 May; 63(1):93-104. PubMed ID: 2939873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).
    Dang-Vu AP; Olsen EA; Vollmer RT; Greenberg ML; Hershfield MS
    J Am Acad Dermatol; 1988 Oct; 19(4):692-8. PubMed ID: 3263401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of 5'-nucleotidase activity and antileukemic effect in 2'-deoxycoformycin therapy.
    Wortmann RL; Holcenberg J; Poplack DG
    Cancer Treat Rep; 1982 Feb; 66(2):387-90. PubMed ID: 6275991
    [No Abstract]   [Full Text] [Related]  

  • 27. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists.
    Camisa C; Grever MR; Bouroncle B
    J Am Acad Dermatol; 1985 Jun; 12(6):1108-9. PubMed ID: 3874216
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolongation of canine skin graft survival by deoxycoformycin.
    Epstein RB; Fey T; Sarpel S
    Transplantation; 1982 Feb; 33(2):208-9. PubMed ID: 7036476
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Johnston JB; Eisenhauer E; Corbett WE; Scott JG; Zaentz SD
    J Natl Cancer Inst; 1988 Jul; 80(10):765-9. PubMed ID: 3290498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.
    Macdonald JS; Marsoni S; Bruno S; Poster D
    Recent Results Cancer Res; 1982; 80():323-30. PubMed ID: 6977170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine deaminase in malaria infection: effect of 2'-deoxycoformycin in vivo.
    Webster HK; Wiesmann WP; Pavia CS
    Adv Exp Med Biol; 1984; 165 Pt A():225-9. PubMed ID: 6609525
    [No Abstract]   [Full Text] [Related]  

  • 33. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
    Kang GJ; Kimball AP
    Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms.
    Spiers AS; Ruckdeschel JC; Horton J
    Scand J Haematol; 1984 Feb; 32(2):130-4. PubMed ID: 6608139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of hairy cell leukemia with 2'-deoxycoformycin: results in India and in the United States.
    Spiers AS; Parekh SJ
    Leukemia; 1987 Apr; 1(4):347-50. PubMed ID: 3499541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
    Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
    Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).
    Spiers AS; Parekh SJ; Bishop MB
    J Clin Oncol; 1984 Dec; 2(12):1336-42. PubMed ID: 6334721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic aspects of hairy cell leukemia].
    Rosa F; Casciaro S; Gatti AM; Boccaccio P; Ghio R
    Recenti Prog Med; 1989 Jan; 80(1):37-44. PubMed ID: 2469113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of hairy-cell leukaemia with 2'-deoxycoformycin.
    Johnston JB; Glazer RI; Pugh L; Israels LG
    Br J Haematol; 1986 Jul; 63(3):525-34. PubMed ID: 3488071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical consequences of treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Paine RM; Smyth JF; Harrap KR
    Adv Exp Med Biol; 1979; 122B():365-71. PubMed ID: 317569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.